BPA - Maxwell RSC 48 system

The Food and Drug Administration is forecasting a Blanket Purchase Agreement for the Maxwell RSC 48 system, a device used for efficient sample preparation in microbiological analysis, intended for deployment across seven microbiology laboratories. Each lab is slated to receive one unit in fiscal year 2026, with the option to add two additional units per year in subsequent years, providing scalability as needs evolve. The agreement is categorized under NAICS code 334516, indicating it relates to laboratory equipment manufacturing, and is structured as a base contract with two option years to support long-term procurement flexibility. The contracting action is posted under the HHS Office of Small and Disadvantaged Business Utilization, with the HFP Acquisition Liaison listed as the primary point of contact for inquiries, while the Contracting Officer position remains to be determined. The purchase will support FDA’s microbiological testing capabilities and is not subject to a specified set-aside classification. All performance and delivery are expected to occur within the U.S., though the precise location is not detailed, and the opportunity is accessible via the official HHS procurement portal for interested vendors.